Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 7
2011 3
2012 2
2015 1
2016 3
2018 2
2019 3
2020 3
2021 5
2022 5
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network. Naccache JM, et al. Among authors: freynet o. Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7. Lancet Respir Med. 2022. PMID: 34506761 Clinical Trial.
Pulmonary Sarcoidosis.
Valeyre D, Bernaudin JF, Jeny F, Duchemann B, Freynet O, Planès C, Kambouchner M, Nunes H. Valeyre D, et al. Among authors: freynet o. Clin Chest Med. 2015 Dec;36(4):631-41. doi: 10.1016/j.ccm.2015.08.006. Clin Chest Med. 2015. PMID: 26593138 Review.
Cardiac sarcoidosis.
Nunes H, Freynet O, Naggara N, Soussan M, Weinman P, Diebold B, Brillet PY, Valeyre D. Nunes H, et al. Among authors: freynet o. Semin Respir Crit Care Med. 2010 Aug;31(4):428-41. doi: 10.1055/s-0030-1262211. Epub 2010 Jul 27. Semin Respir Crit Care Med. 2010. PMID: 20665393 Review.
[Treatment of sarcoidosis].
Londner C, Zendah I, Freynet O, Carton Z, Dion G, Nunes H, Valeyre D. Londner C, et al. Among authors: freynet o. Rev Med Interne. 2011 Feb;32(2):109-13. doi: 10.1016/j.revmed.2010.10.351. Epub 2010 Dec 14. Rev Med Interne. 2011. PMID: 21156331 Review. French.
[Thoracic sarcoidosis].
Nunes H, Uzunhan Y, Freynet O, Naccache JM, Bouvry D, Brillet PY, Valeyre D. Nunes H, et al. Among authors: freynet o. Presse Med. 2010 Jan;39(1):93-106. doi: 10.1016/j.lpm.2009.10.010. Epub 2009 Dec 2. Presse Med. 2010. PMID: 19959325 French.
Pulmonary hypertension complicating sarcoidosis.
Nunes H, Uzunhan Y, Freynet O, Humbert M, Brillet PY, Kambouchner M, Valeyre D. Nunes H, et al. Among authors: freynet o. Presse Med. 2012 Jun;41(6 Pt 2):e303-16. doi: 10.1016/j.lpm.2012.04.003. Epub 2012 May 18. Presse Med. 2012. PMID: 22608948 Review.
Management of sarcoidosis in clinical practice.
Jeny F, Bouvry D, Freynet O, Soussan M, Brauner M, Planes C, Nunes H, Valeyre D. Jeny F, et al. Among authors: freynet o. Eur Respir Rev. 2016 Jun;25(140):141-50. doi: 10.1183/16000617.0013-2016. Eur Respir Rev. 2016. PMID: 27246591 Free PMC article. Review.
[The effect of air pollution in diffuse interstitial lung disease].
Sesé L, Jeny F, Uzunhan Y, Khamis W, Freynet O, Valeyre D, Bernaudin JF, Annesi-Maesano I, Nunes H. Sesé L, et al. Among authors: freynet o. Rev Mal Respir. 2020 May;37(5):389-398. doi: 10.1016/j.rmr.2020.02.015. Epub 2020 Apr 8. Rev Mal Respir. 2020. PMID: 32278507 Review. French.
27 results